Point72 Asset Management’s Nurix Therapeutics NRIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.2M | Buy |
3,703,594
+3,485,141
| +1,595% | +$39.7M | 0.08% | 254 |
|
|
2025
Q1 | $2.6M | Sell |
218,453
-654,506
| -75% | -$7.78M | 0.01% | 764 |
|
|
2024
Q4 | $16.4M | Buy |
+872,959
| New | +$16.4M | 0.04% | 439 |
|
|
2024
Q2 | – | Sell |
-9,500
| Closed | -$140K | – | 1604 |
|
|
2024
Q1 | $140K | Buy |
+9,500
| New | +$140K | ﹤0.01% | 1260 |
|
|
2023
Q4 | – | Sell |
-1,114
| Closed | -$8.76K | – | 1854 |
|
|
2023
Q3 | $8.76K | Buy |
1,114
+1,107
| +15,814% | +$8.7K | ﹤0.01% | 1654 |
|
|
2023
Q2 | $67 | Sell |
7
-9,594
| -100% | -$91.8K | ﹤0.01% | 1538 |
|
|
2023
Q1 | $85.3K | Buy |
+9,601
| New | +$85.3K | ﹤0.01% | 1170 |
|
|
2022
Q2 | – | Sell |
-69,850
| Closed | -$979K | – | 1247 |
|
|
2022
Q1 | $979K | Sell |
69,850
-66,700
| -49% | -$935K | ﹤0.01% | 878 |
|
|
2021
Q4 | $3.95M | Buy |
+136,550
| New | +$3.95M | 0.02% | 672 |
|